Neola Medical

Neola Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neola Medical (NEOLA.ST) as of Oct 16, 2026 is -11.14 M SEK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -9.54 M SEK — a change of 16.81% (lower).

EBITDA

-11.14 MSEK

YoY

16.81%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neola Medical is 2025 -11.14 M SEK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neola Medical was 2024 -9.54 M SEK. It decreases by 16.81% lower compared to the previous year.

The Neola Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-1.26 M SEK
Jan 1, 2019
-3.15 M SEK
Jan 1, 2020
-7.84 M SEK
Jan 1, 2021
-7.34 M SEK
Jan 1, 2022
-9.36 M SEK
Jan 1, 2023
-8.03 M SEK
Jan 1, 2024
-9.54 M SEK
Jan 1, 2025
-11.14 M SEK
The Neola Medical EBITDA history
YEAREBITDAYoY
-11.14 MSEK+16.81%
-9.54 MSEK+18.77%
-8.03 MSEK-14.20%
-9.36 MSEK+27.55%
-7.34 MSEK-6.45%
-7.84 MSEK+148.79%
-3.15 MSEK+150.76%
-1.26 MSEK-66.75%
-3.78 MSEK+60.10%
-2.36 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Neola Medical Stock analysis

What does Neola Medical do? Neola Medical AB is a healthcare company headquartered in Lund, Sweden. The company focuses on the research, development, and commercialization of medical devices. Neola Medical's technology centers on continuous lung monitoring for premature babies using patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. The company went public on October 2, 2020. Its primary product, NEOLA, provides continuous lung monitoring and real-time alerts for life-threatening complications in neonatal intensive care. Neola Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neola Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neola Medical is -11.14 M SEK in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neola Medical changed from -9.54 M SEK to -11.14 M SEK, representing a 16.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Neola Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Neola Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Neola Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Neola Medical